Stakeholder Engagement in Comparative Effectiveness Research Danielle Lavallee, PharmD, PhD Research Assistant Professor UW Department of Surgery July.

Slides:



Advertisements
Similar presentations
©PPRNet 2014 Impact of Patient Engagement on Treatment Decisions and Patient-Centered Outcomes in the Implementation of New Guidelines for the Treatment.
Advertisements

Engaging Patients and Other Stakeholders in Clinical Research
Introduction to the User’s Guide for Developing a Protocol for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research.
1 Palliative Care and Shared Decision-Making HOW TO BECOME AN INFORMED HEALTHCARE DECISION MAKER.
The Community Engagement Studio: Strengthening Research Capacity through Community Engagement Consuelo H. Wilkins, MD, MSCI Executive Director, Meharry.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Sue Sheridan, Acting Director, Patient.
RTI-UNC EPC Issues Exploration Forum (IEF):. Serious Mental Illness Dan Jonas, MD, MPH.
CADTH Therapeutic Reviews
Implementing Patient Decision Aids in Clinical Practice October 2014 Dawn Stacey RN, PhD Research Chair in Knowledge Translation to Patients Full Professor,
Eric R. Johnson Hillsborough County, (Tampa) FL
Stakeholder Engagement and Transparency in The Effective Health Care Program Supriya Janakiraman MD MPH AHRQ.
From Evidence to Action: Addressing Challenges to Knowledge Translation in RHAs The Need to Know Team Meeting May 30, 2005.
Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators.
Joe Selby, MD MPH EBRI December 15, 2011 What Might Patient (Employee)- Centered Research Look Like?
Overview & Brief Introductions Jon F. Kerner, Ph.D. Division of Cancer Control & Population Sciences Lenora Johnson, M.P.H., C.H.E.S. Center for Strategic.
Building for Success: Mental Health Research and Knowledge Exchange in Ontario Heather Bullock, MSc., Manager, Knowledge Exchange, HSRCU, CAMH Aimee Watson,
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Bill Silberg, Director of Communications.
Secondary Translation: Completing the process to Improving Health Daniel E. Ford, MD, MPH Vice Dean Johns Hopkins School of Medicine Introduction to Clinical.
Integrating Knowledge Translation and Exchange into a grant Maureen Dobbins, RN, PhD SON, January 14, 2013.
Consumer Engagement Leadership Consortium 3-4:30pm ET March 28, 2013.
PATIENT-CENTERED OUTCOMES RESEARCH INSTITUTE PCORI Board of Governors Meeting Washington, DC September 24, 2012 Anne Beal, MD, MPH, Chief Operating Officer.
Collaborative Networks for Conducting Comparative Effectiveness Research Tuesday September 9, :00 – 9:30 am.
11 The CPCRN, DCPC, NCI, and the Community Guide: Areas for Collaboration and Supportive Work Shawna L. Mercer, MSc, PhD Director The Guide to Community.
Patient & Family Engagement: a Framework
Patient And Public Involvement (PPI) in Research Dr. Steven Blackburn NIHR Research Design Service West Midlands (Keele University Hub)
Participatory Framework Knowledge, skills and dispositions to create and sustain change are distributed across groups, settings and levels of the system.
Mt. Hood. IOM Report: 10 Years After & More Coming Mitch Greenlick, Ph.D. Oregon State Representative April 21, 2010.
Stakeholder Engagement for Patient-Centered Outcomes Research Vanessa Jacoby, MD, MAS Associate Professor Obstetrics, Gynecology, and Reproductive Sciences.
Component 1: Introduction to Health Care and Public Health in the U.S. 1.9: Unit 9: The evolution and reform of healthcare in the US 1.9c: Quality Indicators.
CRISP Presentation on PCT Study Design: Case Study for Patient-Centered PCTs C. Daniel Mullins, PhD Professor and Chair Pharmaceutical Health Services.
Comparative Effectiveness Research (CER) and Patient- Centered Outcomes Research (PCOR) Presentation Developed for the Academy of Managed Care Pharmacy.
American Association of Colleges of Nursing. © All Rights Reserved. This program generously funded by the Robert Wood Johnson Foundation Evidence-Based.
Improving Data, Improving Outcomes Conference Washington, DC Sept , 2013 Planful Changes: Using Self-Assessments to Improve Child and Family Outcome.
Patient Engagement throughout the Biopharmaceutical Lifecycle: Tips for Effective Patient Advocate/Industry Collaboration to Improve Patient Access and.
Medical Necessity Criteria An Overview of Key Components Presented by BHM Healthcare Solutions.
Community Score Card as a social accountability Approach Methodology and Applications March 2015.
Evaluating the Quality and Impact of Community Benefit Programs
Incorporating Evaluation into a Clinical Project
Developing a guideline
One Approach to Bundled Payments
Community Facilitator Introduction to FORGE AHEAD
Presentation Developed for the Academy of Managed Care Pharmacy
Lou Diamond, MB, ChB, FACP Moderator
Basics of Knowledge Translation
Patient-Oriented Research 101
Patient Involvement in the HTA Decision Making Process
Chapter 13 Case Management
Clinical Studies Continuum
GARD/NCD Action Plan & 2011 UN Summit on NCDs
Hematopoietic Cell Transplantation: Moving Beyond Survival to the Patient’s Perspective Linda J Burns, MD Medical Director, NMDP/Be The Match Health.
EPAs as Curriculum Tools
Presentation Developed for the Academy of Managed Care Pharmacy
RESNA 2018 Annual Conference
Knowledge Translation Across RERC Activities
Jason Gerson, PhD Clinical Effectiveness and Decision Science
Envisioning Consumer Participation
Employing Public and Experts by Experience Researchers (PEERs) for a programme of research in substance misuse and Ageing: a new model of working in addictions.
Eloise Forster, Ed.D. Foundation for Educational Administration (FEA)
Andrea Galgay December 2015
The Center for Nursing Research Ochsner Health System December 2015
Investing in Source Water Protection
Module 5: Formulating Research Questions
Joint BES/BBS Seminar Patient Preference Studies – Introduction
Penn State’s Center for Health Organization Transformation (CHOT)
By: Andi Indahwaty Sidin A Critical Review of The Role of Clinical Governance in Health Care and its Potential Application in Indonesia.
Patient-Centered Outcomes Research Institute (PCORI)
Presentation Developed for the Academy of Managed Care Pharmacy
Impact of quality on day-to-day efforts of PHC
Stirling Bryan, PhD Scientific Director, BC SUPPORT Unit
Data as the Passenger: The Importance of Identifying What Data Matters to the Community Courtney Clyatt Program Officer, Pipeline to Proposal Awards/Engagement.
Presentation transcript:

Stakeholder Engagement in Comparative Effectiveness Research Danielle Lavallee, PharmD, PhD Research Assistant Professor UW Department of Surgery July 13, 2015

Objectives Define stakeholders and stakeholder engagement for research Describe approaches to obtain stakeholder input to inform research Present an approach for planning stakeholder engagement in CER

“Failure to attend to the information and concerns of stakeholders clearly is a kind of flaw in thinking or action that too often and too predictably leads to poor performance, outright failure or even disaster.” ~ J. Bryson, Public Management Review (2004)

Background “Policy-makers and purchasers are interested in identifying sources of cost without benefit. Clinicians need to select effective treatments, and patients want to make informed treatment choices. Outcomes research—the study of the end results of health services that takes patients' experiences, preferences, and values into account—is intended to provide scientific evidence relating to decisions made by all who participate in health care.” ~Clancy CM, Eisenberg JM 1998

Purpose of CER The purpose of CER is to assist consumers, clinicians, purchasers, and policy makers to make informed decisions that will improve health care at both the individual and population levels. Institute of Medicine

Why the focus? Constrained resources Change from acute health to chronic health management Rate of scientific discovery is increasing ─ More to know ─ More to do ─ More to manage (i.e. care coordination) Estimated 17 years for new evidence to reach practice

Increasing Demand

What topics are interesting to research? How do we measure change? Where do we publish? What issues are important to decision- makers? What outcomes are important to inform decision-making? How do we translate into practice? A Paradigm Shift Traditional New Approach

Stakeholders Individuals, organizations or communities that have a direct interest in the process and outcomes of a project, research or policy endeavor Patients & Caregiver s Clinicians Payers & Purchaser s Researche rs Policy- makers

Stakeholder Perspectives StakeholderPerspective Consumers, patients, caregivers, patient advocates Which aspects of an illness are of most concern? Which features of a treatment make the most difference? How are research results best presented and acted upon? Clinicians and Prof Societies What gaps in evidence regarding diagnostic or treatment choices are causing the most harm to patients? What evidence is required to support guidelines or practice pathways that would improve the quality of care? Purchasers and payersWhere does unclear or conflicting evidence cause difficulty in making the decision of what to pay for? Where is new technology or new uses of technology raising questions about what constitutes a standard of care? Health care policymakers at the Federal, State, and local levels Where is new technology or new uses of technology raising questions about what constitutes a standard of care? What research is or could be funded? What evidence is needed to help plan public programs? Industry & Industry Associations Provide unique information about treatments and devices Adapted from the Effective Health Care Program Stakeholder Guide: reports/stakeholderguide/chapter3.html#Stakeholdershttp:// reports/stakeholderguide/chapter3.html#Stakeholders

Stakeholder Engagement A process of actively soliciting the knowledge, experience, judgment and values of individuals selected to represent a broad range of direct interests in a particular issue, for the dual purposes of: 1) Creating a shared understanding; 2) Making relevant, transparent, and effective decisions. Deverka PA, Lavallee DC, Desai PJ, Esmail LC, Ramsey SD, Veenstra DL, Tunis SR. Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement. Journal of Comparative Effectiveness Research, 2012; 1(2):

Qualitative Approaches to Engagement Preskill H, Jones N. A practical guide for engaging stakeholders in developing evaluation questions. Robert Wood Johnson Foundation. Available at:

Where to Start? Not a traditional aspect of clinical research No standard approach exists Timelines can be tight so plan early!

Why? Why am I planning to engage stakeholders in my research? ─ Do I want help prioritizing research? ─ Do I want to understand what outcomes are important? ─ Do I want to understand how stakeholders seek/use information? What are the risks and opportunities for engagement? ─ Is this a contentious topic? ─ What are the risks of not engaging stakeholders? Why not? ─ If stakeholders are not included – understand and articulate why they are not directly involved

Who? Who are my stakeholders? ─ What perspectives are needed and why? Consider diversity in both populations represented & opinions present ─ Who from each group is best to engage? Which one(s) - advocates versus patients/caregivers versus consumers? What role/position does the person hold? Does the person need decision-making power?

Perspectives & Needs Vary Research Activity Why?Characteristics of Who? Topic Prioritization Protocol Development Translation & Dissemination

Research Activity Why?Characteristics of Who? Topic Prioritization Identify gaps in evidence Identify priorities Identify dissemination avenues Possess broad perspective Access to a larger community Funders?? Protocol Development Identify comparators for research Identify populations of interest Identify outcomes of interest Decision-makers Current topic experience/knowledge Translation & Dissemination Help craft messaging Identify venues for presenting Representatives of target audience Communication/editorial experience a bonus! Perspectives & Needs Vary

What? What are the objectives of engaging stakeholders? ─ Developing research guidance ─ Developing a research agenda ─ Designing a research plan ─ Disseminating information What are the methods for engaging stakeholders? ─ Members of research teams ─ Members of an advisory group ─ Qualitative approaches (Focus group, Surveys, interviews)

When and Where? When will stakeholder engagement occur in the process? How frequently will engagement occur? ─ One-time engagement vs. engagement throughout the life of a project ─ For long-term activities considers approaches to sustain and maintain involvement Where will activities be conducted? ─ In-person? Conference call?

How? How will we measure success? ─ What criteria will be used? ─ How will evaluations occur (survey, interview, etc) How will we incorporate findings for improvement? How will we inform stakeholders of progress?

Stakeholder Engagement in Practice: Working Examples

Research Proposal Development Engaged with Patients, Clinicians, Healthcare Administrators, Funders, and Researchers Multiple approaches to engagement utilized Planning over 7 months Non-funded work

Stakeholders as Advisors Back pain Outcomes using Longitudinal Data (BOLD) ARRA Funded Registry Multi-stakeholder Advisory Group ─ Receive updates on research ─ Advise on study issues/challenges ─ Discuss findings of research ─ Discuss future research opportunities ─ Assist with dissemination activities

Final thoughts Patient/stakeholder engagement plans should link to the research plan Allot time for planning and involving stakeholders Build relationships – collaboration becomes easier when you know the stakeholder landscape Evaluate the process from both the stakeholder and research team’s perspective Document activities and results

Take Home: Planning Tool Stakeholder Why is this stakeholder important to engage? What issues are important to this stakeholder? What are the expectations for engaging with this stakeholder? Are there any particular skills or experience that this stakeholder should have (i.e. personal experience, policy development, clinical practice) How might this stakeholder be engaged throughout the research continuum?

Questions?